Literature DB >> 31658331

Immunoexpression of E-cadherin, P-cadherin and fibronectin in gastric carcinomas.

Maria Dobriţoiu1, Alex Emilian Stepan, Claudiu Mărgăritescu, Cristiana Eugenia Simionescu, Cristin Constantin Vere, Michael Schenker, Anda Elena Crişan.   

Abstract

One of the mechanisms involved in gastric carcinomas progression is represented by epithelial-mesenchymal transition (EMT), a complex process during which tumor cells acquire an invasive and migratory mesenchymal phenotype. In this study, we analyzed the immunoexpression of E-cadherin, P-cadherin and fibronectin in 50 gastric carcinomas, in relation with the tumoral type, differentiation grade and lesions stage. The reactions presented variable patterns related to lesions stage. Membrane and cytoplasmic reactions were present in 62% of cases for E-cadherin and in 56% of cases for P-cadherin, being present only cytoplasmic in 34% of cases for fibronectin. The immunoexpression for E-cadherin and P-cadherin was superior in tubular gastric carcinomas, of low grade and early stage, while fibronectin expression was superior in discohesive or mixed gastric carcinomas, of high grade and in advanced stages. Negative E-∕P-cadherin and positive fibronectin immunophenotype may be associated with aggressive gastric carcinomas and supports the EMT involvement in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31658331

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  3 in total

1.  Jinlian Xiaodu Decoction Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats.

Authors:  Zhiqiang Wu; Qin He; Feibao Tao; Xuxing Ye; Saibin Wang; Yijun Zhu; Liang Zhu; Bin Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-23       Impact factor: 2.650

Review 2.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

3.  Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG.

Authors:  Jeannette Huaman; Olorunseun O Ogunwobi
Journal:  Cells       Date:  2020-07-01       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.